Meet the Team: Luke Hall

After completing his BSc (Bachelor of Science) and MSc (Masters in Science) Luke Hall was ready to take the next step in his career.

While searching for local PhD projects, Luke came across upcoming opportunities at the Heart Research Institute. After one visit to meet the team and see our research facilities, he made the decision to further his research career with us.

Luke joined our Free Radical Group, where his current project is examining the role of thiocyanate on cardiovascular disease. 

Thiocyanate is a compound found in certain nuts and vegetables as well as a detoxification product of cyanide from cigarette smoke. 

“Hopefully, by the end of my project we will have a better idea whether thiocyanate is beneficial or detrimental in the context of both atherosclerosis (thickened arteries) and heart attacks" says Luke.

"If it is beneficial, thiocyanate may be a cheap and easy way of reducing the incidence of heart disease”, he adds.

Luke is well aware that regular donations are what makes his work possible. “There are many great people at The HRI striving every day to make crucial discoveries that will ultimately improve global heart and cardiovascular health. I hope to figure out my small piece of the puzzle of cardiovascular disease, so that one day what I learn can potentially contribute to a cure.”


Related news

Meet the Team: Dr David Pattison

Dr David Pattison was appointed as joint leader of the Free Radical Group in 2014. David is a dedicated and highly accomplished researcher, and is also a Senior Research Fellow at the Sydney Medical School, University of Sydney.

Read more

The HRI discovers new selenium compounds

The Free Radical Group has shown that a number of novel compounds containing selenium atoms can act as efficient antioxidants, protecting the body against damage caused by a variety of oxidants produced during inflammation. 

Read more

Marcus Blackmore Fellow undertaking drug toxicity study

Dr Carmine Gentile, Marcus Blackmore Fellow at The Heart Research Institute, will be researching the development of a novel drug toxicity screening technique.

Read more